58.01
price up icon1.60%   0.915
after-market Dopo l'orario di chiusura: 58.01 0.005 +0.01%
loading
Precedente Chiudi:
$57.09
Aprire:
$56.76
Volume 24 ore:
374.03K
Relative Volume:
1.09
Capitalizzazione di mercato:
$1.18B
Reddito:
$1.77M
Utile/perdita netta:
$-123.74M
Rapporto P/E:
-6.3255
EPS:
-9.17
Flusso di cassa netto:
$-95.21M
1 W Prestazione:
+5.58%
1M Prestazione:
+31.95%
6M Prestazione:
-24.78%
1 anno Prestazione:
+1.57%
Intervallo 1D:
Value
$55.96
$58.44
Intervallo di 1 settimana:
Value
$53.72
$59.10
Portata 52W:
Value
$26.70
$91.83

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name
Nome
Praxis Precision Medicines Inc
Name
Telefono
617-300-8460
Name
Indirizzo
99 HIGH STREET, 30TH FLOOR, BOSTON
Name
Dipendente
82
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
PRAX's Discussions on Twitter

Confronta PRAX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PRAX
Praxis Precision Medicines Inc
58.01 1.16B 1.77M -123.74M -95.21M -9.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-02 Ripresa Oppenheimer Outperform
2025-05-07 Iniziato Chardan Capital Markets Buy
2025-03-03 Reiterato H.C. Wainwright Buy
2025-02-11 Iniziato Deutsche Bank Buy
2024-08-05 Iniziato Oppenheimer Outperform
2024-06-24 Iniziato Needham Buy
2024-06-18 Iniziato Guggenheim Buy
2024-05-01 Iniziato Robert W. Baird Outperform
2023-09-19 Iniziato Truist Buy
2022-06-06 Downgrade Wedbush Outperform → Neutral
2021-12-16 Iniziato H.C. Wainwright Buy
2021-08-26 Iniziato BofA Securities Buy
2021-04-26 Iniziato William Blair Outperform
2020-11-11 Iniziato Wedbush Outperform
2020-11-10 Iniziato Cowen Outperform
2020-11-10 Iniziato Evercore ISI Outperform
2020-11-10 Iniziato Piper Sandler Overweight
Mostra tutto

Praxis Precision Medicines Inc Borsa (PRAX) Ultime notizie

pulisher
Jul 24, 2025

Is Praxis Precision Medicines Inc. a good long term investmentExceptional profit potential - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Will Praxis Precision Medicines Inc. stock benefit from AI tech trendsTremendous return rates - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Praxis Precision Medicines Inc. stock outlookSky-high return potential - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Praxis Precision Medicines Inc. Stock Analysis and ForecastFree Risk Assessment Services - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Praxis Precision Medicines Inc. stockBreakthrough capital growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Praxis Precision Medicines Inc. stock priceConsistent triple-digit returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Major Depressive Disorder Clinical Trials, Companies, - openPR.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Praxis Precision Medicines Inc. stock price move sharplyFree Stock Selection - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Does Praxis Precision Medicines Inc. stock pay reliable dividendsShort Squeeze Radar - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Why Praxis Precision Medicines Inc. stock attracts strong analyst attentionGroup Only Stock Signals - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Praxis Precision Medicines’ (PRAX) Buy Rating Reiterated at HC Wainwright - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

(PRAX) Trading Report - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

Here's Why We're Not Too Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Situation - 富途牛牛

Jul 19, 2025
pulisher
Jul 18, 2025

Praxis Precision Medicines stock gets BTD for relutrigine, H.C. Wainwright maintains Buy - Investing.com Nigeria

Jul 18, 2025
pulisher
Jul 18, 2025

Praxis Precision Medicines stock gets BTD for relutrigine, H.C. Wainwright maintains Buy By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

PRAX: HC Wainwright & Co. Reiterates Buy Rating with $105 Target - GuruFocus

Jul 18, 2025
pulisher
Jul 17, 2025

Praxis Precision gets FDA breakthrough therapy status for Relutrigine - Seeking Alpha

Jul 17, 2025
pulisher
Jul 17, 2025

FDA grants breakthrough therapy designation to Praxis’ relutrigine for pediatric epilepsy - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Q1 Earnings Forecast for PRAX Issued By HC Wainwright - Defense World

Jul 17, 2025
pulisher
Jul 17, 2025

Praxis Precision Medicines and the Breakthrough Potential of Relutrigine in Rare Epilepsy Therapies: Strategic and Financial Implications of FDA Breakthrough Therapy Designation - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Praxis Says FDA Grants Breakthrough Therapy Designation To Relutrigine For Rare Pediatric Epilepsies - Nasdaq

Jul 17, 2025
pulisher
Jul 17, 2025

FDA grants breakthrough therapy status to Praxis’s relutrigine By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

FDA grants breakthrough therapy status to Praxis’s relutrigine - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Praxis Precision Medicines Gains FDA Breakthrough Designation - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

PRAX Gains FDA Breakthrough Designation for Pediatric Epilepsy D - GuruFocus

Jul 17, 2025
pulisher
Jul 17, 2025

Praxis Precision Medicines Receives Breakthrough Therapy Designation for Relutrigine in Pediatric Developmental and Epileptic Encephalopathies - Quiver Quantitative

Jul 17, 2025
pulisher
Jul 17, 2025

Praxis Precision Medicines Receives FDA Breakthrough - GlobeNewswire

Jul 17, 2025
pulisher
Jul 17, 2025

Praxis's Rare Epilepsy Drug Achieves FDA Breakthrough Status: 90% Seizure Reduction in Trial Patients - Stock Titan

Jul 17, 2025

Praxis Precision Medicines Inc Azioni (PRAX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):